In an eagerly awaited milestone for the company – and for Belgian biotech – the FDA approved ThromboGenics NV's biologic drug Jetrea (ocriplasmin) for treating symptomatic vitreomacular adhesion (VMA).
Covagen AG signed its first drug discovery deal, a pact worth potentially up to €112.25 million (US$146 million) with Mitsubishi Tanabe Pharma Corp. that involves its Fynomer protein scaffold technology.
Shares in Wilex AG plunged 60 percent just before the markets closed in Frankfurt, Germany, Tuesday, on news that a protracted Phase III trial of Rencarex (girentuximab) failed to meet the primary endpoint of disease-free survival in patients with clear cell renal carcinoma (ccRCC).
Genmedica Therapeutics SL raised €12 million (US$15.5 million) in a Series B round to move its first-in-class drug candidate, GMC-252, into a Phase I trial in Type II diabetes.
Genmedica Therapeutics SL raised €12 million (US$15.5 million) in a Series B round to move its first-in-class drug candidate, GMC-252, into a Phase I trial in Type II diabetes.
BRUSSELS – The smooth sounds of Marvin Gaye's '80s classic 'Sexual Healing' greeted delegates filing in for the opening keynote session at BioPartnering Future Europe meeting at the Square Brussels Meeting Centre Monday.
BRUSSELS, Belgium – Continuing the habit of starting the day's proceedings with unexpected musical choices, the audio-visual technician in charge of the Silver Hall meeting room chose Louis Armstrong's and Ella Fitzgerald's inimitable rendition of "Let's call the whole thing off" to kick off Tuesday's sessions at the BioPartnering Future Europe meeting at the Square Brussels Meeting Centre Tuesday.
BRUSSELS, Belgium – Continuing the habit of starting the day's proceedings with unexpected musical choices, the audio-visual technician in charge of the Silver Hall meeting room chose Louis Armstrong's and Ella Fitzgerald's inimitable rendition of "Let's call the whole thing off" to kick off Tuesday's sessions at the BioPartnering Future Europe meeting at the Square Brussels Meeting Centre Tuesday.
BRUSSELS – The smooth sounds of Marvin Gaye's '80s classic 'Sexual Healing' greeted delegates filing in for the opening keynote session at BioPartnering Future Europe meeting at the Square Brussels Meeting Centre Monday.
Evotec AG is pocketing €12 million (US$15.5 million) up front and could receive up to €580 million more in preclinical, clinical and commercial milestones from a drug discovery alliance focused on endometriosis with Bayer Pharma AG.
